$0.22
1.03% yesterday
Nasdaq, Aug 12, 10:19 pm CET
ISIN
US74275C2052
Symbol
PCSA

Processa Pharmaceuticals Inc Stock price

$0.22
+0.01 2.99% 1M
-0.39 63.80% 6M
-0.66 75.03% YTD
-1.24 84.88% 1Y
-64.18 99.66% 3Y
-169.78 99.87% 5Y
-979.78 99.98% 10Y
-2,057.78 99.99% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
-0.00 1.03%
ISIN
US74275C2052
Symbol
PCSA
Industry

Key metrics

Basic
Market capitalization
$11.2m
Enterprise Value
$8.3m
Net debt
positive
Cash
$2.9m
Shares outstanding
5.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
3.2
Financial Health
Equity Ratio
52.5%
Return on Equity
-707.5%
ROCE
-342.4%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-12.1m | -
EBIT
$-12.1m | $-11.1m
Net Income
$-12.0m | $-2.9m
Free Cash Flow
$-11.9m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-19.0% | -
EBIT
-18.9% | 7.2%
Net Income
-21.7% | 75.8%
Free Cash Flow
-49.1%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-1.3
FCF per Share
$-2.3
Short interest
11.3%
Employees
10
Rev per Employee
$0.0
Show more

Is Processa Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Processa Pharmaceuticals Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Processa Pharmaceuticals Inc forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Processa Pharmaceuticals Inc forecast:

Buy
75%
Hold
25%

Financial data from Processa Pharmaceuticals Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 4.77 4.77
7% 7%
-
- Research and Development Expense 7.32 7.32
28% 28%
-
-12 -12
19% 19%
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -12 -12
19% 19%
-
Net Profit -12 -12
22% 22%
-

In millions USD.

Don't miss a Thing! We will send you all news about Processa Pharmaceuticals Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Processa Pharmaceuticals Inc Stock News

Neutral
GlobeNewsWire
5 days ago
VERO BEACH, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies for cancer patients, today announced that it has secured a strategic investment and that it is evaluating corporate cryptocurrency treasury strategies as part of its broader financial and growth objectives.
Neutral
GlobeNewsWire
about one month ago
Signed binding term sheet granting Intact Therapeutics an exclusive option to license PCS12852 Continue enrolling patients in Phase 2 study of PCS6422 Strengthened balance sheet with $7M capital infusion VERO BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage pharmaceutical company developing next-generation cancer therapies, provides ...
Neutral
GlobeNewsWire
about 2 months ago
HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (the “Company”), a clinical-stage pharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced the pricing of a public offering of 28,000,000 shares of common stock (or pre-funded warrants in lieu thereof), together with common warrants to purchase up to 28,000,000 shares o...
More Processa Pharmaceuticals Inc News

Company Profile

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its product pipeline is PCS499, which is use for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on October 2, 2017 and is headquartered in Hanover, MD.

Head office United States
CEO George Ng
Employees 10
Founded 2011
Website www.processapharmaceuticals.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today